Search Results - "Kolenc Peitl, Petra"

Refine Results
  1. 1

    Radiolabelled CCK2R Antagonists Containing PEG Linkers: Design, Synthesis and Evaluation by Novak, Doroteja, Tomašič, Tihomir, Krošelj, Marko, Javornik, Uroš, Plavec, Janez, Anderluh, Marko, Kolenc Peitl, Petra

    Published in ChemMedChem (08-01-2021)
    “…The cholecystokinin‐2/gastrin receptor (CCK2R) is considered a suitable target for the development of radiolabelled antagonists, due to its overexpression in…”
    Get full text
    Journal Article
  2. 2

    Superior Diagnostic Performance of the GLP-1 Receptor Agonist [Lys40(AhxHYNIC-[99mTc]/EDDA)NH2]-Exendin-4 over Conventional Imaging Modalities for Localization of Insulinoma by Senica, Katra, Tomazic, Ales, Skvarca, Ales, Kolenc Peitl, Petra, Mikolajczak, Renata, Hubalewska-Dydejczyk, Alicja, Lezaic, Luka

    Published in Molecular imaging and biology (01-02-2020)
    “…Purpose Insulinomas are the most common functioning neuroendocrine neoplasms of the pancreas, typically diagnosed due to characteristic symptoms. In the vast…”
    Get full text
    Journal Article
  3. 3

    Current Status of Radiopharmaceuticals for the Theranostics of Neuroendocrine Neoplasms by Fani, Melpomeni, Peitl, Petra Kolenc, Velikyan, Irina

    Published in Pharmaceuticals (Basel, Switzerland) (15-03-2017)
    “…Nuclear medicine plays a pivotal role in the management of patients affected by neuroendocrine neoplasms (NENs). Radiolabeled somatostatin receptor analogs are…”
    Get full text
    Journal Article Book Review
  4. 4

    Clinical translation of theranostic radiopharmaceuticals: Current regulatory status and recent examples by Kolenc Peitl, Petra, Rangger, Christine, Garnuszek, Piotr, Mikolajczak, Renata, Hubalewska‐Dydejczyk, Alicja, Maina, Theodosia, Erba, Paola, Decristoforo, Clemens

    “…With the development of ever more radiopharmaceuticals suitable for theranostic applications, translation of novel compounds from the preclinical stage towards…”
    Get full text
    Journal Article
  5. 5

    EANM guideline on the validation of analytical methods for radiopharmaceuticals by Gillings, Nic, Todde, Sergio, Behe, Martin, Decristoforo, Clemens, Elsinga, Philip, Ferrari, Valentina, Hjelstuen, Olaug, Peitl, Petra Kolenc, Koziorowski, Jacek, Laverman, Peter, Mindt, Thomas L., Ocak, Meltem, Patt, Marianne

    Published in EJNMMI radiopharmacy and chemistry (12-02-2020)
    “…Background To fulfil good manufacturing requirements, analytical methods for the analysis of pharmaceuticals for human and vetinary use must be validated. The…”
    Get full text
    Journal Article
  6. 6
  7. 7

    CCK2R antagonists: from SAR to clinical trials by Novak, Doroteja, Anderluh, Marko, Kolenc Peitl, Petra

    Published in Drug discovery today (01-08-2020)
    “…•The CCK2 receptor is involved in numerous (patho)physiological processes.•Many CCK2 receptor antagonists have shown promising results in in-vivo animal…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    A novel, self-shielded modular radiosynthesis system for fully automated preparation of PET and therapeutic radiopharmaceuticals by Kroselj, Marko, Socan, Aljaz, Zaletel, Katja, Dreger, Thorsten, Knopp, Roger, Gmeiner, Tanja, Kolenc Peitl, Petra

    Published in Nuclear medicine communications (01-02-2016)
    “…OBJECTIVEWith the vast development of theranostics and, recently, Ga-radiolabeled molecules, there is also a need for novel, smaller, flexible, safe, and…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    Radiooznačeni peptidi v nuklearni medicini by Krošelj, Marko, Kolenc Peitl, Petra, Sočan, Aljaž, Leskovec, Marijana, Mlinarič-Raščan, Irena, Gmeiner, Tanja

    “…Nuklearna medicina pri obravnavi onkoloških bolnikov omogoča slikovni prikaz oziroma lokalizacijo tumorjev, ciljano zdravljenje ter spremljanje uspešnosti…”
    Get full text
    Journal Article
  16. 16

    CCK 2 R antagonists: from SAR to clinical trials by Novak, Doroteja, Anderluh, Marko, Kolenc Peitl, Petra

    Published in Drug discovery today (01-08-2020)
    “…The widespread involvement of the cholecystokinin-2/gastrin receptor (CCK R) in multiple (patho)physiological processes has propelled extensive searches for…”
    Get full text
    Journal Article
  17. 17

    Radiolabelled CCK 2 R Antagonists Containing PEG Linkers: Design, Synthesis and Evaluation by Novak, Doroteja, Tomašič, Tihomir, Krošelj, Marko, Javornik, Uroš, Plavec, Janez, Anderluh, Marko, Kolenc Peitl, Petra

    Published in ChemMedChem (08-01-2021)
    “…The cholecystokinin-2/gastrin receptor (CCK R) is considered a suitable target for the development of radiolabelled antagonists, due to its overexpression in…”
    Get full text
    Journal Article
  18. 18

    Stereochemistry of amino acid spacers determines the pharmacokinetics of (111)In-DOTA-minigastrin analogues for targeting the CCK2/gastrin receptor by Kolenc Peitl, Petra, Tamma, MariaLuisa, Kroselj, Marko, Braun, Friederike, Waser, Beatrice, Reubi, Jean Claude, Sollner Dolenc, Marija, Maecke, Helmut R, Mansi, Rosalba

    Published in Bioconjugate chemistry (17-06-2015)
    “…The metabolic instability and high kidney retention of minigastrin (MG) analogues hamper their suitability for use in peptide-receptor radionuclide therapy of…”
    Get full text
    Journal Article
  19. 19

    Imaging and 1-day kinetics of intracoronary stem cell transplantation in patients with idiopathic dilated cardiomyopathy by Lezaic, Luka, Socan, Aljaz, Peitl, Petra Kolenc, Poglajen, Gregor, Sever, Matjaz, Cukjati, Marko, Cernelc, Peter, Vrtovec, Bojan

    Published in Nuclear medicine and biology (01-07-2016)
    “…Abstract Background Stem cell transplantation is an emerging method of treatment for patients with cardiovascular disease. There are few studies completed or…”
    Get full text
    Journal Article
  20. 20